Gene-modified bone marrow cell therapy for prostate cancer.
about
Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer model.Adenoviral-mediated endothelial precursor cell delivery of soluble CD115 suppresses human prostate cancer xenograft growth in mice.Chemokine markers predict biochemical recurrence of prostate cancer following prostatectomy.
P2860
Gene-modified bone marrow cell therapy for prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gene-modified bone marrow cell therapy for prostate cancer.
@en
Gene-modified bone marrow cell therapy for prostate cancer.
@nl
type
label
Gene-modified bone marrow cell therapy for prostate cancer.
@en
Gene-modified bone marrow cell therapy for prostate cancer.
@nl
prefLabel
Gene-modified bone marrow cell therapy for prostate cancer.
@en
Gene-modified bone marrow cell therapy for prostate cancer.
@nl
P2860
P356
P1433
P1476
Gene-modified bone marrow cell therapy for prostate cancer.
@en
P2093
P2860
P2888
P304
P356
10.1038/GT.2008.37
P577
2008-04-03T00:00:00Z